• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PriceSmart, Kura Sushi And 3 Stocks To Watch Heading Into Wednesday

    7/10/24 3:25:50 AM ET
    $AZZ
    $ICCC
    $KRUS
    $MANU
    Industrial Specialties
    Industrials
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $AZZ alert in real time by email

    With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

    • Wall Street expects Manchester United Plc. (NYSE:MANU) to report a quarterly loss at 27 cents per share on revenue of $162.92 million before the opening bell, according to data from Benzinga Pro. Manchester United shares gained 1.6% to $16.19 in the after-hours trading session.
    • Kura Sushi USA (NASDAQ:KRUS) posted downbeat results for its third quarter on Tuesday. Kura Sushi shares fell 4.2% to $56.00 in the after-hours trading session.
    • Analysts are expecting PriceSmart, Inc. (NASDAQ:PSMT) to post quarterly earnings at $1.01 per share on revenue of $1.21 billion. The company will release earnings after the markets close. PriceSmart shares gained 1% to $79.00 in after-hours trading.

    Check out our premarket coverage here

    • ImmuCell Corporation (NASDAQ:ICCC) reported preliminary sales results for the second quarter. The company said it sees preliminary sales of $5.47 million up from $3.53 million in the year-ago period. ImmuCell shares climbed 8.9% to $4.67 in the after-hours trading session.
    • Analysts expect AZZ Inc. (NYSE:AZZ) to post quarterly earnings at $1.30 per share on revenue of $402.05 million. AZZ shares gained 2.7% to $77.00 in after-hours trading.

    Check This Out:

    • Delta Air Lines Likely To Report Lower Q2 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

    Photo courtesy: PriceSmart

    Get the next $AZZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZZ
    $ICCC
    $KRUS
    $MANU

    CompanyDatePrice TargetRatingAnalyst
    Kura Sushi USA Inc.
    $KRUS
    3/6/2026$90.00Buy
    DA Davidson
    AZZ Inc.
    $AZZ
    3/2/2026$132.00Overweight → Equal Weight
    Wells Fargo
    AZZ Inc.
    $AZZ
    8/14/2025$128.00Overweight
    Wells Fargo
    AZZ Inc.
    $AZZ
    6/9/2025$101.00Buy → Neutral
    Sidoti
    AZZ Inc.
    $AZZ
    4/9/2025$101.00Neutral → Buy
    Sidoti
    Kura Sushi USA Inc.
    $KRUS
    2/25/2025$72.00Hold
    TD Cowen
    Kura Sushi USA Inc.
    $KRUS
    2/21/2025$103.00Hold → Buy
    Lake Street
    AZZ Inc.
    $AZZ
    2/11/2025$108.00Buy
    ROTH MKM
    More analyst ratings

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: President and CEO Te Boekhorst Paul Francis Olivier bought $31,528 worth of Common Stock $0.10 par value per share (6,030 units at $5.23), increasing direct ownership by 163% to 9,738 units (SEC Form 4)

    4/A - IMMUCELL CORP /DE/ (0000811641) (Issuer)

    12/4/25 4:11:39 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    President and CEO Te Boekhorst Paul Francis Olivier bought $48,588 worth of Common Stock $0.10 par value per share (9,785 units at $4.97) (SEC Form 4)

    4 - IMMUCELL CORP /DE/ (0000811641) (Issuer)

    12/3/25 4:14:14 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Tomsche David Scott bought $15,554 worth of Common Stock $0.10 par value per share (3,266 units at $4.76), increasing direct ownership by 3% to 52,720 units (SEC Form 4)

    4 - IMMUCELL CORP /DE/ (0000811641) (Issuer)

    11/28/25 8:12:55 AM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AZZ Inc. to Review Fourth Quarter and Fiscal Year 2026 Financial Results on Thursday, April 23, 2026

    FORT WORTH, Texas, March 31, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced it will conduct a conference call to review the Company's financial results for the fourth quarter and fiscal year 2026 at 11:00 a.m. ET on Thursday, April 23, 2026. The Company will issue a press release reporting fourth quarter and full fiscal year financial results after the market closes on Wednesday, April 22, 2026. Conference Call DetailsInterested parties can access the conference call by dialing (844) 8

    3/31/26 4:15:00 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

    PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced that Kathy Turner has been appointed to its Board of Directors, effective April 1, 2026. Ms. Turner replaces Steven Rosgen, who is retiring from the Board after serving since January 2018. Upon joining the Board, Ms. Turner will serve as Chair of the Compensation and Stock Option Committee and as a member of the Audit Committee. Ms. Turner brings more than three decades of commercial executive leadership experience in global healthcar

    3/18/26 4:05:00 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Kura Sushi USA to Announce Fiscal Second Quarter 2026 Financial Results on April 7, 2026

    IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company"), (NASDAQ:KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal second quarter 2026 financial results on Tuesday, April 7, 2026, at 5:00 p.m. ET. A press release with fiscal second quarter 2026 financial results will be issued that same day after the market closes. Hosting the conference call and webcast will be Hajime "Jimmy" Uba, President and Chief Executive Officer, Jeff Uttz, Chief Financial Officer, and Benjamin Porten, SVP Investor Relations & System Development. Interested parties may listen to the conferenc

    3/17/26 9:00:00 AM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Reece John

    3 - Manchester United plc (0001549107) (Issuer)

    4/1/26 1:42:07 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form 3 filed by new insider Turner Kathy V

    3 - IMMUCELL CORP /DE/ (0000811641) (Issuer)

    4/1/26 9:06:19 AM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 3 filed by new insider Leitao Robert

    3 - Manchester United plc (0001549107) (Issuer)

    3/31/26 3:35:03 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson initiated coverage on Kura Sushi with a new price target

    DA Davidson initiated coverage of Kura Sushi with a rating of Buy and set a new price target of $90.00

    3/6/26 8:34:12 AM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    AZZ downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded AZZ from Overweight to Equal Weight and set a new price target of $132.00

    3/2/26 8:53:30 AM ET
    $AZZ
    Industrial Specialties
    Industrials

    Wells Fargo initiated coverage on AZZ with a new price target

    Wells Fargo initiated coverage of AZZ with a rating of Overweight and set a new price target of $128.00

    8/14/25 8:21:16 AM ET
    $AZZ
    Industrial Specialties
    Industrials

    $AZZ
    $ICCC
    $KRUS
    $MANU
    SEC Filings

    View All

    SEC Form 10-K filed by ImmuCell Corporation

    10-K - IMMUCELL CORP /DE/ (0000811641) (Filer)

    3/30/26 5:34:38 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by PriceSmart Inc.

    SCHEDULE 13G/A - PRICESMART INC (0001041803) (Subject)

    3/27/26 11:21:34 AM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    ImmuCell Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - IMMUCELL CORP /DE/ (0000811641) (Filer)

    3/18/26 4:05:54 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Leadership Updates

    Live Leadership Updates

    View All

    ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board

    PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivity, today announced that Kathy Turner has been appointed to its Board of Directors, effective April 1, 2026. Ms. Turner replaces Steven Rosgen, who is retiring from the Board after serving since January 2018. Upon joining the Board, Ms. Turner will serve as Chair of the Compensation and Stock Option Committee and as a member of the Audit Committee. Ms. Turner brings more than three decades of commercial executive leadership experience in global healthcar

    3/18/26 4:05:00 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    AZZ Inc. Announces Corporate Governance and Other Board Succession Changes

    FORT WORTH, Texas, March 5, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the appointment of Aaron Schapper, age 52, and Charles "Chuck" Treadway, age 60, to serve as new members of AZZ's Board of Directors, effective April 8, 2026 which is AZZ's first Board meeting of fiscal year 2027. Mr. Schapper currently serves as President, Chief Executive Officer and a member of the Board of Directors of Myers Industries Inc., a manufacturer of sustainable plastic and metal products that protec

    3/5/26 6:30:00 AM ET
    $AZZ
    Industrial Specialties
    Industrials

    Kura Sushi USA Announces Election of Claudia Schaefer to the Company's Board of Directors

    IRVINE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company"), (NASDAQ:KRUS), a technology-enabled Japanese restaurant concept, today announced that Claudia Schaefer has been elected to serve as an independent member of the Board of Directors effective January 21, 2026. In conjunction with Ms. Schaefer's nomination, Kim Ellis did not stand for re-election as a director, also effective January 21, 2026. Hajime Uba, President, Chief Executive Officer and Chairman of Kura Sushi, stated, "We are thrilled to announce the election of Claudia to Kura Sushi USA's Board of Directors. Claudia's deep brand and marketing background makes her an excellent addit

    1/22/26 4:05:00 PM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Financials

    Live finance-specific insights

    View All

    AZZ Inc. to Review Fourth Quarter and Fiscal Year 2026 Financial Results on Thursday, April 23, 2026

    FORT WORTH, Texas, March 31, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced it will conduct a conference call to review the Company's financial results for the fourth quarter and fiscal year 2026 at 11:00 a.m. ET on Thursday, April 23, 2026. The Company will issue a press release reporting fourth quarter and full fiscal year financial results after the market closes on Wednesday, April 22, 2026. Conference Call DetailsInterested parties can access the conference call by dialing (844) 8

    3/31/26 4:15:00 PM ET
    $AZZ
    Industrial Specialties
    Industrials

    Kura Sushi USA to Announce Fiscal Second Quarter 2026 Financial Results on April 7, 2026

    IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company"), (NASDAQ:KRUS), a technology-enabled Japanese restaurant concept, today announced that it will host a conference call to discuss fiscal second quarter 2026 financial results on Tuesday, April 7, 2026, at 5:00 p.m. ET. A press release with fiscal second quarter 2026 financial results will be issued that same day after the market closes. Hosting the conference call and webcast will be Hajime "Jimmy" Uba, President and Chief Executive Officer, Jeff Uttz, Chief Financial Officer, and Benjamin Porten, SVP Investor Relations & System Development. Interested parties may listen to the conferenc

    3/17/26 9:00:00 AM ET
    $KRUS
    Restaurants
    Consumer Discretionary

    PriceSmart Announces Earnings Release and Conference Call Details for the Second Quarter of Fiscal 2026

    SAN DIEGO, March 6, 2026 /PRNewswire/ -- PriceSmart, Inc. ("PriceSmart" or the "Company") (NASDAQ:PSMT) plans to release financial results for the second quarter of fiscal year 2026 on Wednesday, April 8, 2026, after the market closes. PriceSmart management will host a conference call at 12:00 p.m. Eastern time (9:00 a.m. Pacific time) on Thursday, April 9, 2026, to discuss the financial results. Individuals interested in participating in the conference call may do so by dialing toll free (800) 715-9871 for domestic callers or +1 (646) 307-1963 for international callers and asking to join the PriceSmart earnings call. A digital replay will be available shortly following the conclusion of the

    3/6/26 4:45:00 PM ET
    $PSMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AZZ
    $ICCC
    $KRUS
    $MANU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Manchester United Ltd.

    SC 13G/A - Manchester United plc (0001549107) (Subject)

    11/14/24 4:14:22 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Manchester United Ltd.

    SC 13G/A - Manchester United plc (0001549107) (Subject)

    11/14/24 4:06:32 PM ET
    $MANU
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by AZZ Inc.

    SC 13G/A - AZZ INC (0000008947) (Subject)

    11/14/24 1:28:29 PM ET
    $AZZ
    Industrial Specialties
    Industrials